Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...

Read about a new tool that has been developed from a nurse-led study aiming to support more lung cancer patients into ...

Johnson & Johnson said on Monday it has discontinued a late-stage study testing its experimental drug to treat a type of ...

Yufei Liu, MD, PhD, discussed the importance of careful data interpretation to accurately assess the efficacy of new ...

We recommend a Hold on Benitec Biopharma due to speculative nature and early-stage progress, but worth watching for potential ...

Merck & Co. hopes a new positive trial readout can return Keytruda to glory in head and neck cancer. | Merck & Co. hopes a ...

Stories from Connecticut's witch trials will be shown in "Goodwives and the Gallows: Tales from the Connecticut Witchcraft ...

Lung cancer is rare in people under 45, but rates are rising in non-smokers, particularly women. Tiffany Job was shocked to ...

We interviewed Sangeeta Shukla, Ph. D., a Bioinformatics Scientist for the Children’s Hospital of Philadelphia. We asked her ...

The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...